Benzinga | Aug 12, 2021 04:27PM EDT

Cormedix Q2 EPS $(0.12) Beats $(0.17) Estimate

Cormedix (AMEX:CRMD) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.17) by 29.41 percent.